http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-201306840-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1bde28565d28f037e78bf4a67776ee24
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4965
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-454
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4515
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-554
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D241-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18
filingDate 2012-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_efdc3480a460a6e49f48bb23a4236662
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7534cea6000c8719daa0abfd235a5a73
publicationDate 2013-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber TW-201306840-A
titleOfInvention Administration of 4-((1R,3S)-6-chloro-3-phenyl-indan-1-yl)-1,2,2-trimethyl-piperidin as a salt for the treatment of schizophrenia Methods
abstract The present invention relates to 4-((1R,3S)-6-chloro-3-phenyl-dihydroindol-1-yl)-1,2 which is active against dopamine D1 and D2 receptors and serotonin 5HT2 receptor. , 2-trimethyl-piperidin and its salts for the treatment of central nervous system disorders in a weekly dosing regimen.
priorityDate 2011-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419484542
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5073
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419497889
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507434
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410072001
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419533573
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419592315
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507378
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25423
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69550
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3033769
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID219077
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60795
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398737
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536136
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6954
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8032
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60149
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492896
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11318
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507462
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419550067
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3693574
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507324
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5002
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419499849
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410510661
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492710
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1049
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60854
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419477881
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11465618
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398745
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67304917
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419545310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419480399
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3559
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431688682
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547992
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID166734

Total number of triples: 70.